Navigation Links
Trial finds more support for universal HIV screening in emergency departments
Date:8/5/2013

CINCINNATIScreening everyone for HIV in the emergency department may be superior to testing only those with apparent risk, when trying to identify patients with undiagnosed HIV infection, according to a new results by researchers at the University of Cincinnati (UC).

Though the U.S. Centers for Disease Control and Prevention and national research organizations have recommended universal HIV screening, lead author Michael Lyons, MD, says there is still disagreement among physicians on how to implement screening in the nation's already busy emergency departments. Lyons, an assistant professor of emergency medicine, directs UC's HIV Early Intervention Program, which provides HIV screenings in the University of Cincinnati Medical Center emergency department and in community-based settings around Cincinnati.

Proponents of targeted testingwho argue that it is more beneficial to perform fewer tests but have more tests be positivesay limiting HIV screening to those with identified risk reduces the number of tests emergency departments have to perform, saving time and cost.

Opponents say that targeting only those at risk is insufficient because it misses cases. However, Lyons says, previous trials do not delineate whether cases have been missed because testing criteria are limited or because screening was not applied to enough patients to provide clear results.

"More selective HIV screening is thought to miss more cases, but there have never been well-designed comparison studies on which targeting criteria are best," he says, "so with this study, we hypothesized that by using very broad criteria and applying sufficient resources to test everyone who met those criteria, we could detect nearly as many cases as universal screening but still use many fewer tests."

In the randomized trial, patients receiving universal screening were offered an HIV test regardless of their risk factors. For patients randomized to targeted screening, researchers intentionally set very broad parameters, offering HIV testing for any possible risk indicator that could be identified, many more criteria than are usually considered.

There were 9,572 patients approached to offer screening. Contrary to expectations, targeted screening did not diagnose nearly as many patients and did not require that many fewer tests.

For patients screened universally, approximately 40 percent consented to testing and six patients were newly diagnosed.

For patients receiving targeted screening, 47 percent consented and three patients were newly diagnosed. Overall, Lyons says the number of tests saved by targeting led to similar reductions in new cases detected.

"This shows that this method of targeted screening, using with broadest possible selection criteria, offers no important advantage over universal screening," says Lyons. "We will need other studies to discover whether some other method of selecting patients for HIV screening could succeed, where this method did not, in limiting testing while still detecting most cases.

The team's results, "Randomized Comparison of Universal and Targeted HIV Screening in the Emergency Department," are published online ahead of print in the Journal of Acquired Immune Deficiency Syndromes.


'/>"/>

Contact: Katy Cosse
kathryn.cosse@uc.edu
513-558-0207
University of Cincinnati Academic Health Center
Source:Eurekalert

Related medicine news :

1. Tumor cell vaccination trial to promote anti-leukemia responses
2. Vaginal Mesh Lawsuit Bellwether Trial Is Underway As Jury Selection Is Finalized, Reports Wright & Schulte
3. Several Korein Tillery Lawyers Nominated as Finalists for the Public Justice “Trial Lawyer of the Year” Award
4. Apixaban in atrial fibrillation: Indications of considerable added benefit
5. Mesothelioma Victims Center Now Focuses On Ensuring Industrial Workers Diagnosed With Mesothelioma Have Instant Access To The Nations Most Skilled Mesothelioima Attorneys
6. Block O'Toole & Murphy, LLP Personal Injury Trial Lawyers Take $2,270,000 Verdict In Brooklyn Motor Vehicle Accident Case
7. NuvaRing Bellwether Trial Scheduled: Now, AttorneyOne Can Provide Advice
8. Mesh Lawsuit Trial: Bernstein Liebhard LLP Notes Selection of Jury in Federal C.R. Bard Vaginal Mesh Lawsuit Trial
9. New poll shows minority populations support clinical trials to improve health of others
10. Triple Anti-Oxidant Liver Formula, a Proactive Approach to Dealing with Environmental Toxins, is Now Available for a Complimentary Trial
11. Doyle Raizner Pradaxa Case Chosen for Bellwether Early Trial Consideration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , ... January 18, 2017 , ... ... asset protection and financial planning services to families and business owners in the ... aimed at supporting children with developmental disabilities. , The Lakemary Center is a ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent ... for drugs, biologics and consumer health products, today announced that Mr. Michael Merges, ... upcoming WCBP Conference, to be held at the Mayflower Hotel, Washington DC, on ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... the revolutionary Active Brake Technology (ABT), an innovative braking system that allows skaters ... Brake Technology addresses one of the biggest concerns of beginner and intermediate skaters ...
(Date:1/17/2017)... Michigan (PRWEB) , ... January 17, 2017 , ... January is National Stalking Awareness ... who choose to lurk in the corners and commit the crime of stalking, a very ... use and addiction, an often overlooked factor in stalking and other crimes. , “Stalking: know ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... point of difference. Eden Activewear is a stand-out company for several differences from ... online and only manufacture on demand, this is called 'Agile' manufacturing - ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, announces ... DMT210, in a Phase 2 acne rosacea study. ... downregulate the proinflammatory cytokines in the skin responsible ... rosacea. This clinical trial, DMT210-003, ...
(Date:1/18/2017)... Safe Rx LLC and Good Day Pharmacy, ... Loveland, Colorado , today announced the availability ... Day locations.     "Patients with prescriptions prone ... storage," said Milton Cohen , President & CEO ... a cup of coffee, you can protect your children ...
(Date:1/18/2017)... In China , we say Health is ... China,s Healthy Strategy originates. 2016 is ... and Social Development of the People,s Republic of ... council of the People,s Republic of China ... plan, identifying medical devices as one of the main breakthrough ...
Breaking Medicine Technology: